The potential effect of KRAS inhibitors on tumor microenvironments

被引:0
作者
Tanaka, Noritaka
Sakamoto, Takeharu
机构
关键词
D O I
10.1158/1535-7163.TARG-23-C175
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
C175
引用
收藏
页数:2
相关论文
共 50 条
[31]   Hydrogels to engineer tumor microenvironments in vitro [J].
Fernando, Kanishka ;
Kwang, Leng Gek ;
Lim, Joanne Tze Chin ;
Fong, Eliza Li Shan .
BIOMATERIALS SCIENCE, 2021, 9 (07) :2362-2383
[32]   Targeting KRAS with reversible inhibitors [J].
Sarah Crunkhorn .
Nature Reviews Drug Discovery, 2022, 21 (5) :338-338
[33]   A breakout year for KRAS inhibitors [J].
不详 .
CHEMICAL & ENGINEERING NEWS, 2019, 97 (47) :36-36
[34]   Efforts to Develop KRAS Inhibitors [J].
Holderfield, Matthew .
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2018, 8 (07)
[35]   EGFR inhibitors embrace KRAS [J].
Sheridan, Cormac .
NATURE BIOTECHNOLOGY, 2008, 26 (08) :839-840
[36]   KRAS inhibitors: going noncovalent [J].
Drosten, Matthias ;
Barbacid, Mariano .
MOLECULAR ONCOLOGY, 2022, 16 (22) :3911-3915
[37]   A bright future for KRAS inhibitors [J].
Dafna Bar-Sagi ;
Erik H. Knelson ;
Lecia V. Sequist .
Nature Cancer, 2020, 1 :25-27
[38]   A bright future for KRAS inhibitors [J].
Bar-Sagi, Dafna ;
Knelson, Erik H. ;
Sequist, Lecia V. .
NATURE CANCER, 2020, 1 (01) :25-27
[39]   Macrophages in Tumor Microenvironments and the Progression of Tumors [J].
Hao, Ning-Bo ;
Lu, Mu-Han ;
Fan, Ya-Han ;
Cao, Ya-Ling ;
Zhang, Zhi-Ren ;
Yang, Shi-Ming .
CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2012,
[40]   Tumor microenvironments in 3D [J].
Madhura Mukhopadhyay .
Nature Methods, 2022, 19 :138-138